Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individualsMarco Bongiovanni, Antonella d’Arminio Monforte, Paola Cicconi et al.|International Journal of Antimicrobial Agents|2005Cited by 33
Virological Success of Lopinavir/Ritonavir Salvage Regimen is Affected by an Increasing Number of Lopinavir/Ritonavir-Related MutationsMarco Bongiovanni, Antonella d’Arminio Monforte, Teresa Bini et al.|Antiviral Therapy|2003Cited by 25
Predictive Factors of Hyperlipidemia in HIV-Infected Subjects Receiving Lopinavir/RitonavirMarco Bongiovanni, Antonella d’Arminio Monforte, Teresa Bini et al.|AIDS Research and Human Retroviruses|2006Cited by 17
Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort studyDavide Fiore Bavaro, Michele Bartoletti, Lidia Dalfino et al.|International Journal of Infectious Diseases|2025Cited by 4
Reply to Comment on “Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of Candida bloodstream infections: A retrospective multicenter cohort study”Davide Fiore Bavaro, Michele Bartoletti, Lucia Diella et al.|International Journal of Infectious Diseases|2025Cited by 0